Navigation Links
Cardiac Device Won't Help Some Heart Failure Patients
Date:11/6/2007

They performed no better with Cardiac Resynchronization Therapy, researchers say

TUESDAY, Nov. 6 (HealthDay News) -- Heart failure patients treated with a device that synchronizes pumping in the heart's ventricles showed no improvement in exercise capacity, researchers report.

The results were presented Tuesday at a late-breaking clinical trial session at the American Heart Association's annual meeting, in Orlando, Fla., and were expected to be published in the Dec. 13 print issue of the New England Journal of Medicine.

Cardiac Resynchronization Therapy (CRT) devices are surgically implanted and deliver electrical impulses to both ventricles at the same time, making both chambers contract simultaneously and thereby improving pumping efficiency.

While current guidelines support using CRT in patients with moderate to severe heart failure, this study aimed to see if the device could benefit patients outside those recommended parameters.

For this trial, 172 heart failure patients were randomly assigned to receive treatment with CRT or not.

Those treated with CRT showed no significant improvement in exercise capacity as measured by peak oxygen consumption. Some symptoms did improve, but quality-of-life scores and results of the six-minute hall walk test did not change significantly, the researchers reported.

"There was no significant difference in the change in peak oxygen consumption between the treatment group and the control group during cardiopulmonary testing," Dr. John Beshai, study lead author and director of pacemaker and defibrillator services in the division of cardiology at the University of Chicago, said at a news conference Tuesday. "Further research is necessary," he said.

The trial was funded by St. Jude Medical, which makes the CRT device.

More information

There's more on heart failure at the American Heart Association.



-- Amanda Gardner



SOURCES: Nov. 6, 2007, American Heart Association news conference with John Beshai, M.D., director of pacemaker and defibrillator services, division of cardiology, University of Chicago; Dec. 13, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: